[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers

By Atia Musazay

May 14, 2014

A breakthrough drug now on the market could be a potential cure for hepatitis C. But with its costly price tag of $1,000, or $84,000 for a 12-week treatment, the state of Washington is concerned that not everyone who needs the medication will be able to afford it.

[button title=”Read More” link=”http://www.bizjournals.com/seattle/blog/health-care-inc/2014/05/1-000-a-pill-hepatitis-c-drug-may-be-too-costly.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_seattle+%28Seattle+-+Puget+Sound+Business+Journal%29&page=all” target=”_blank” size=”” color=”” class=””]